246 related articles for article (PubMed ID: 7546822)
1. Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
Horsman MR
Acta Oncol; 1995; 34(5):571-87. PubMed ID: 7546822
[TBL] [Abstract][Full Text] [Related]
2. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
Chaplin DJ; Horsman MR; Siemann DW
Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
[TBL] [Abstract][Full Text] [Related]
3. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
Horsman MR; Nordsmark M; Khalil AA; Hill SA; Chaplin DJ; Siemann DW; Overgaard J
Acta Oncol; 1994; 33(4):371-6. PubMed ID: 8018368
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
Rojas A; Vojnovic B; Johns H; Joiner MC; Martindale C; Fowler JF; Denekamp J
Radiother Oncol; 1996 Apr; 39(1):53-64. PubMed ID: 8735494
[TBL] [Abstract][Full Text] [Related]
5. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
Ono K; Masunaga S; Akuta K; Akaboshi M; Abe M
Radiother Oncol; 1993 Aug; 28(2):162-7. PubMed ID: 8248558
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of agents counteracting hypoxia in fractionated radiation regimes.
Stern S; Guichard M
Radiother Oncol; 1996 Nov; 41(2):143-9. PubMed ID: 9004358
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
Dorie MJ; Menke D; Brown JM
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
[TBL] [Abstract][Full Text] [Related]
8. A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.
Kjellen E; Joiner MC; Collier JM; Johns H; Rojas A
Radiother Oncol; 1991 Oct; 22(2):81-91. PubMed ID: 1835542
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
Chaplin DJ; Horsman MR; Aoki DS
Br J Cancer; 1991 Jan; 63(1):109-13. PubMed ID: 1846549
[TBL] [Abstract][Full Text] [Related]
10. Chemical radiosensitizers for use in radiotherapy.
Wardman P
Clin Oncol (R Coll Radiol); 2007 Aug; 19(6):397-417. PubMed ID: 17478086
[TBL] [Abstract][Full Text] [Related]
11. Preferential tumor radiosensitization by analogs of nicotinamide and benzamide.
Horsman MR; Brown DM; Lemmon MJ; Brown JM; Lee WW
Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1307-10. PubMed ID: 2944859
[TBL] [Abstract][Full Text] [Related]
12. Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay.
McLaren DB; Pickles T; Thomson T; Olive PL
Radiother Oncol; 1997 Nov; 45(2):175-82. PubMed ID: 9424009
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships for tumour radiosensitization by analogues of nicotinamide and benzamide.
Brown JM; Lemmon MJ; Horsman MR; Lee WW
Int J Radiat Biol; 1991 Mar; 59(3):739-48. PubMed ID: 1672362
[TBL] [Abstract][Full Text] [Related]
14. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
Siemann DW; Horsman MR; Chaplin DJ
Radiother Oncol; 1994 May; 31(2):117-22. PubMed ID: 8066190
[TBL] [Abstract][Full Text] [Related]
15. Improvement of tumor oxygenation by mild hyperthermia.
Song CW; Park H; Griffin RJ
Radiat Res; 2001 Apr; 155(4):515-28. PubMed ID: 11260653
[TBL] [Abstract][Full Text] [Related]
16. Comparison of low dose nicotinamide versus benzamide, administered per os, as radiosensitizers in a C3H mammary carcinoma.
Kjellen E; Pero RW; Nilsson P
Radiother Oncol; 1988 Aug; 12(4):327-31. PubMed ID: 2973086
[TBL] [Abstract][Full Text] [Related]
17. The effect of combined nicotinamide and carbogen treatments in human tumour xenografts: oxygenation and tumour control studies.
Stüben G; Stuschke M; Knühmann K; Horsman MR; Sack H
Radiother Oncol; 1998 Aug; 48(2):143-8. PubMed ID: 9783885
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide.
Bussink J; Kaanders JH; Van der Kogel AJ
Acta Oncol; 1999; 38(7):875-82. PubMed ID: 10606417
[TBL] [Abstract][Full Text] [Related]
19. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy.
Rojas A; Hirst VK; Calvert AS; Johns H
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):357-65. PubMed ID: 8567336
[TBL] [Abstract][Full Text] [Related]
20. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
Saunders M; Dische S
Br J Cancer Suppl; 1996 Jul; 27():S271-8. PubMed ID: 8763896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
